PT977562E - Metodos e composicoes para administracao de taxanos - Google Patents

Metodos e composicoes para administracao de taxanos

Info

Publication number: PT977562E
Authority: PT; Portugal
Prior art keywords: compositions; methods; tax administration; taxol; delivery
Prior art date: 1998-03-10

Application number

PT99909941T

Other languages

English (en)

Inventor

Lisa L Mcchesney-Harris

Original Assignee

Tapestry Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-10

Filing date

1999-03-10

Publication date

2006-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22138176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT977562(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-03-10 Application filed by Tapestry Pharmaceuticals Inc filed Critical Tapestry Pharmaceuticals Inc

2006-05-31 Publication of PT977562E publication Critical patent/PT977562E/pt

Links

239000000203 mixture Substances 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
229930012538 Paclitaxel Natural products 0.000 abstract 2
229960001592 paclitaxel Drugs 0.000 abstract 2
229940123237 Taxane Drugs 0.000 abstract 1
AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 abstract 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
125000002456 taxol group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Epoxy Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

PT99909941T 1998-03-10 1999-03-10 Metodos e composicoes para administracao de taxanos PT977562E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7745998P	1998-03-10	1998-03-10

Publications (1)

Publication Number	Publication Date
PT977562E true PT977562E (pt)	2006-05-31

Family

ID=22138176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99909941T PT977562E (pt)	1998-03-10	1999-03-10	Metodos e composicoes para administracao de taxanos

Country Status (17)

Country	Link
US (1)	US20010029264A1 (pt)
EP (1)	EP0977562B8 (pt)
JP (1)	JP2001524988A (pt)
KR (1)	KR20010012363A (pt)
CN (1)	CN1255852A (pt)
AT (1)	ATE314844T1 (pt)
AU (1)	AU762926B2 (pt)
BR (1)	BR9904856A (pt)
CA (1)	CA2288240A1 (pt)
CY (1)	CY1105690T1 (pt)
DE (1)	DE69929313T2 (pt)
DK (1)	DK0977562T3 (pt)
ES (1)	ES2257038T3 (pt)
IL (1)	IL131217A0 (pt)
PT (1)	PT977562E (pt)
WO (1)	WO1999045918A1 (pt)
ZA (1)	ZA991885B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6964946B1 (en) *	1995-10-26	2005-11-15	Baker Norton Pharmaceuticals, Inc.	Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US6245805B1 (en) *	1995-10-26	2001-06-12	Baker Norton Pharmaceuticals, Inc.	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6040330A (en) *	1999-01-08	2000-03-21	Bionumerik Pharmaceuticals, Inc.	Pharmaceutical formulations of taxanes
EP1479382A1 (en) *	1999-06-18	2004-11-24	IVAX Research, Inc.	Oral pharmaceutical compositions containing taxanes and methods for treatment employing the same
US6136846A (en)	1999-10-25	2000-10-24	Supergen, Inc.	Formulation for paclitaxel
US6828346B2 (en) *	1999-10-25	2004-12-07	Supergen, Inc.	Methods for administration of paclitaxel
CA2397871A1 (en) *	2000-01-20	2001-07-26	Supratek Pharma Inc.	Novel podophyllotoxin compositions
MXPA01009900A (es) *	2000-02-02	2003-08-20	Univ Florida State Res Found	Formulaciones de taxano que tienen solubilidad mejorada.
JP2004536026A (ja)	2000-11-28	2004-12-02	トランスフォームファーマシューティカルズ，インコーポレーティッド．	パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
WO2002064132A2 (en) *	2001-01-18	2002-08-22	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US7115565B2 (en)	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
AU2002351169B2 (en) *	2001-11-26	2007-09-20	Intas Pharmaceuticals Limited	Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
US20040092428A1 (en) *	2001-11-27	2004-05-13	Hongming Chen	Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
CA2470826A1 (en) *	2001-12-20	2003-07-03	Bristol-Myers Squibb Company	Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
EP1340497A1 (en) *	2002-03-01	2003-09-03	Novagali Sas	Self emulsifying drug delivery systems for poorly soluble drugs
ES2283756T3 (es) *	2002-03-01	2007-11-01	Novagali Pharma Sa	Sistemas autoemulsionantes de administracion de farmaco para taxoides.
NZ537829A (en)	2002-07-30	2006-09-29	Wyeth Corp	Parenteral formulations containing a rapamycin hydroxyester
DE10244847A1 (de)	2002-09-20	2004-04-01	Ulrich Prof. Dr. Speck	Medizinische Vorrichtung zur Arzneimittelabgabe
AU2002350719A1 (en) *	2002-11-29	2004-06-23	Janssen Pharmaceutica N.V.	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
US20040127551A1 (en) *	2002-12-27	2004-07-01	Kai Zhang	Taxane-based compositions and methods of use
EP2181704B1 (en) *	2002-12-30	2015-05-06	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
WO2004091506A2 (en) *	2003-04-10	2004-10-28	Ivax Research, Inc.	Taxane-based compositions and methods of use
EP1498120A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Semi-solid formulations for the oral administration of taxoids
EP1510206A1 (en) *	2003-08-29	2005-03-02	Novagali Pharma SA	Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
CA2552925A1 (en) *	2004-01-30	2005-08-18	Pfizer Italia S.R.L.	Semisolid matrix pharmaceutical formulations
WO2005074889A1 (en) *	2004-02-03	2005-08-18	Dinesh Shantilal Patel	Novel compositions of taxol derivatives and the process for the manufacture thereof
US8003122B2 (en)	2004-03-31	2011-08-23	Cordis Corporation	Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7989490B2 (en)	2004-06-02	2011-08-02	Cordis Corporation	Injectable formulations of taxanes for cad treatment
US7345093B2 (en)	2004-04-27	2008-03-18	Formatech, Inc.	Methods of enhancing solubility of compounds
US7659310B2 (en)	2004-04-27	2010-02-09	Formatech, Inc.	Methods of enhancing solubility of agents
JP2008514714A (ja) *	2004-09-30	2008-05-08	イーストマンケミカルカンパニー	有意な流出阻害を示さない、親油性薬物を可溶化するビタミンｅｔｐｇｓ分子を含む医薬製剤及びこのような医薬製剤の使用
US20070167422A1 (en) *	2006-01-18	2007-07-19	Yu Kwok S	Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
EP2271214B1 (en) *	2008-03-28	2017-05-03	Particle Sciences, Inc.	Pharmaceutical solutions and method for solubilizing therapeutic agents
US8409601B2 (en)	2008-03-31	2013-04-02	Cordis Corporation	Rapamycin coated expandable devices
CN102000052B (zh) *	2008-06-25	2012-12-12	重庆市中药研究院	紫杉醇及其衍生物在制药中的应用
US10143652B2 (en)	2009-09-23	2018-12-04	Curirx Inc.	Methods for the preparation of liposomes
CA2781529C (en)	2009-09-23	2017-10-24	Indu Javeri	Methods for the preparation of liposomes comprising docetaxel
US20120065255A1 (en) *	2009-10-19	2012-03-15	Nagesh Palepu	Cabazitaxel formulations and methods of preparing thereof
EA027666B1 (ru)	2010-05-03	2017-08-31	ТЕИКОКУ ФАРМА ЮСЭй, ИНК.	Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования
WO2012096859A2 (en) *	2011-01-10	2012-07-19	Celgene Corporation	Oral dosage forms of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl]-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide
JO3685B1 (ar)	2012-10-01	2020-08-27	Teikoku Pharma Usa Inc	صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
EP3302423B1 (en)	2015-06-04	2022-05-25	Crititech, Inc.	Particle production system and particle collection device
CA2998483C (en)	2015-09-16	2022-09-06	Dfb Soria, Llc	Delivery of drug nanoparticles and methods of use thereof
BR112018069628A2 (pt)	2016-04-04	2019-02-12	Crititech, Inc.	métodos para tratamento de tumor sólido
WO2018170196A1 (en)	2017-03-15	2018-09-20	Dfb Soria, Llc	Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
EP3615145B1 (en)	2017-06-09	2024-05-15	Crititech, Inc.	Compositions for use in the treatment of epithelial cysts by intracystic injection of antineoplastic particles
WO2018231908A1 (en)	2017-06-14	2018-12-20	Crititech, Inc.	Methods for treating lung disorders
KR20250057947A (ko)	2017-10-03	2025-04-29	크리티테크, 인크.	암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
US11497726B2 (en)	2018-03-16	2022-11-15	Dfb Soria, Ll.	Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4228162A (en) *	1979-07-09	1980-10-14	Research Corporation	Dimethyl isosorbide in liquid formulation of aspirin
US4578391A (en) *	1982-01-20	1986-03-25	Yamanouchi Pharmaceutical Co., Ltd.	Oily compositions of antitumor drugs
US4942184A (en) *	1988-03-07	1990-07-17	The United States Of America As Represented By The Department Of Health And Human Services	Water soluble, antineoplastic derivatives of taxol
US4960790A (en) *	1989-03-09	1990-10-02	University Of Kansas	Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
ES2224200T3 (es) *	1992-11-27	2005-03-01	Mayne Pharma (Usa) Inc.	Composicion inyectable estable de paclitaxel.
WO1995011039A1 (de) *	1993-10-22	1995-04-27	Hexal Pharma Gmbh	Pharmazeutische zusammensetzung mit cyclosporin a und alpha-tocopherol
US5877205A (en) *	1996-06-28	1999-03-02	Board Of Regents, The University Of Texas System	Parenteral paclitaxel in a stable non-toxic formulation
US6458373B1 (en) *	1997-01-07	2002-10-01	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs

1998
- 1998-03-10 IL IL13121798A patent/IL131217A0/xx unknown
1999
- 1999-03-09 ZA ZA9901885A patent/ZA991885B/xx unknown
- 1999-03-10 KR KR19997010315A patent/KR20010012363A/ko not_active Withdrawn
- 1999-03-10 DK DK99909941T patent/DK0977562T3/da active
- 1999-03-10 WO PCT/US1999/005151 patent/WO1999045918A1/en not_active Ceased
- 1999-03-10 EP EP99909941A patent/EP0977562B8/en not_active Expired - Lifetime
- 1999-03-10 PT PT99909941T patent/PT977562E/pt unknown
- 1999-03-10 CA CA002288240A patent/CA2288240A1/en not_active Abandoned
- 1999-03-10 DE DE69929313T patent/DE69929313T2/de not_active Expired - Fee Related
- 1999-03-10 BR BR9904856-6A patent/BR9904856A/pt not_active Application Discontinuation
- 1999-03-10 AU AU29022/99A patent/AU762926B2/en not_active Ceased
- 1999-03-10 AT AT99909941T patent/ATE314844T1/de not_active IP Right Cessation
- 1999-03-10 CN CN99800022A patent/CN1255852A/zh active Pending
- 1999-03-10 JP JP54602599A patent/JP2001524988A/ja not_active Ceased
- 1999-03-10 ES ES99909941T patent/ES2257038T3/es not_active Expired - Lifetime
2001
- 2001-02-28 US US09/795,626 patent/US20010029264A1/en not_active Abandoned
2006
- 2006-03-29 CY CY20061100438T patent/CY1105690T1/el unknown

Also Published As

Publication number	Publication date
CY1105690T1 (el)	2010-12-22
ATE314844T1 (de)	2006-02-15
CA2288240A1 (en)	1999-09-16
JP2001524988A (ja)	2001-12-04
ES2257038T3 (es)	2006-07-16
DE69929313D1 (de)	2006-03-30
ZA991885B (en)	1999-09-10
MX9910340A (en)	2000-04-01
BR9904856A (pt)	2000-07-18
WO1999045918A1 (en)	1999-09-16
EP0977562A1 (en)	2000-02-09
AU762926B2 (en)	2003-07-10
CN1255852A (zh)	2000-06-07
EP0977562B8 (en)	2006-04-26
AU2902299A (en)	1999-09-27
KR20010012363A (ko)	2001-02-15
EP0977562B1 (en)	2006-01-04
DK0977562T3 (da)	2006-05-01
US20010029264A1 (en)	2001-10-11
IL131217A0 (en)	2001-01-28
DE69929313T2 (de)	2006-08-17

Publication	Publication Date	Title
PT977562E (pt)	2006-05-31	Metodos e composicoes para administracao de taxanos
DK0902789T3 (da)	2002-05-06	Androstenderivater
NO964433L (no)	1996-10-18	Farmasöytiske preparater på basis av derivater av taxanklassen
ATE383169T1 (de)	2008-01-15	Komponente und zusammensetzungen zur verabreichung von wirkstoffen
EP1100522A4 (en)	2003-01-08	ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
IL140930A0 (en)	2002-02-10	Compounds and compositions for delivering active agents
TR200101481T2 (tr)	2001-09-21	Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
CY1108610T1 (el)	2014-04-09	Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR9810495A (pt)	2000-09-12	Composição farmacêutica
BR0110837A (pt)	2003-03-11	Quimioterapia de combinação
ATE311373T1 (de)	2005-12-15	Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
EA200301023A1 (ru)	2004-02-26	Заместительная терапия эстрогенами
WO2002078690A3 (en)	2002-11-21	Taxoid anti-tumor agents and pharmaceutical compositions thereof
PT1135169E (pt)	2003-06-30	Uso de uma composicao farmaceutica compreendendo um agente anti-canceroso e pelo menos um peptideo
CY1106311T1 (el)	2011-10-12	Χορηγηση απο το στομα παραγωγων ταξοειδων
ECSP982396A (es)	1999-01-12	Composiciones que contienen tetrahidrolipstatina
MX9604984A (es)	1998-02-28	Composiciones farmaceuticas a base de derivados de la clase de los taxanos.
UA42376A (uk)	2001-10-15	Склад для догляду за нігтями